Skip to main content
Top
Published in: Abdominal Radiology 4/2003

01-07-2003 | Pictorial essay

Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging

Authors: K. Takahama, Y. Amano, H. Hayashi, M. Ishihara, T. Kumazaki

Published in: Abdominal Radiology | Issue 4/2003

Login to get access
Metadata
Title
Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging
Authors
K. Takahama
Y. Amano
H. Hayashi
M. Ishihara
T. Kumazaki
Publication date
01-07-2003
Publisher
Springer New York
Published in
Abdominal Radiology / Issue 4/2003
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-002-0064-9

Other articles of this Issue 4/2003

Abdominal Radiology 4/2003 Go to the issue

Feature section

Introduction

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine